We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+5.5%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$281M
AUM Growth
-$10.8M
Cap. Flow
-$24.3M
Cap. Flow %
-8.63%
Top 10 Hldgs %
39.74%
Holding
374
New
13
Increased
43
Reduced
92
Closed
35
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
201
Walmart Inc
WMT
$820B
$22K 0.01%
900
GLNG icon
202
Golar LNG
GLNG
$5.13B
$21K 0.01%
750
JCI icon
203
Johnson Controls International
JCI
$84.6B
$21K 0.01%
501
UNP icon
204
Union Pacific
UNP
$183B
$21K 0.01%
200
FCOR icon
205
Fidelity Corporate Bond ETF
FCOR
$351M
$20K 0.01%
400
MCHP icon
206
Microchip Technology
MCHP
$39.6B
$20K 0.01%
+538
New +$19K
MPC icon
207
Marathon Petroleum
MPC
$104B
$20K 0.01%
400
NQP
208
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$20K 0.01%
1,558
NWL icon
209
Newell Brands
NWL
$2.63B
$20K 0.01%
426
BDX icon
210
Becton Dickinson
BDX
$51.6B
$19K 0.01%
104
KLAC icon
211
KLA
KLAC
$229B
$19K 0.01%
2,000
-1,000
-33% -$8.81K
TXT icon
212
Textron
TXT
$14.3B
$19K 0.01%
400
CALM icon
213
Cal-Maine
CALM
$3.75B
$18K 0.01%
500
CMD
214
DELISTED
Cantel Medical Corporation
CMD
$18K 0.01%
230
-150
-39% -$11.9K
ANDE icon
215
Andersons Inc
ANDE
$2.19B
$17K 0.01%
450
BIDU icon
216
Baidu
BIDU
$32.9B
$17K 0.01%
100
CC icon
217
Chemours
CC
$2.35B
$17K 0.01%
436
DXCM icon
218
DexCom
DXCM
$34.3B
$17K 0.01%
800
NOC icon
219
Northrop Grumman
NOC
$77.5B
$17K 0.01%
70
ZLTQ
220
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$17K 0.01%
300
FDS icon
221
Factset
FDS
$11B
$16K 0.01%
100
ROX
222
DELISTED
Castle Brands, Inc.
ROX
$16K 0.01%
10,000
CHRW icon
223
C.H. Robinson
CHRW
$17.6B
$15K 0.01%
200
FMAT icon
224
Fidelity MSCI Materials Index ETF
FMAT
$622M
$15K 0.01%
500
IWP icon
225
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$15K 0.01%
284

Similar funds

American Research & Management Company's Q1 2017 Portfolio in Review

As of Q1 2017, American Research & Management Company held 374 positions worth $281M, down 3.7% from $292M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

American Research & Management Company withdrew a net $24.3M in Q1 2017, closing 35 positions and reducing 92 holdings. Its most notable exit was PrivateBancorp, Inc. Capital Trust IV Trust Preferred, an estimated $5.61M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, American Research & Management Company opened a new position in Bioverativ Inc. Common Stock worth $397K.

  • American Research & Management Company's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 7,291 shares worth $397K.
  • American Research & Management Company added most to NVIDIA in Q1 2017, an estimated $1.29M increase.
  • American Research & Management Company's biggest Q1 2017 reduction was Allied World Assurance Co Hld Lt, cutting an estimated $3.73M.
  • American Research & Management Company fully exited PrivateBancorp, Inc. Capital Trust IV Trust Preferred in Q1 2017, selling an estimated $5.61M.
  • American Research & Management Company's ten largest holdings make up 40% of its $281M portfolio in Q1 2017.
  • American Research & Management Company opened 13 new positions and closed 35 in Q1 2017.
  • American Research & Management Company's portfolio value fell 3.7% quarter-over-quarter to $281M.

Based on American Research & Management Company's 13F filing for Q1 2017, filed 17 Apr 2017.